Digital therapeutics (DTx): what they are and how they are transforming healthcare

Digital therapeutics, often abbreviated as DTx, are software-based therapeutic interventions, clinically validated, designed to prevent, manage, or treat specific conditions.

They are not simple health apps

The difference is crucial. An app that reminds you to drink water is not a DTx. A software solution validated by clinical trials, with a measurable therapeutic effect on a specific condition, is.

How they are regulated

In Europe, they fall under the Medical Device Regulation (MDR). In the U.S., they are classified by the FDA. In both cases, the process includes clinical validation, certification, and post-market monitoring.

Where they are already used

• Mental health: anxiety disorders, depression, insomnia.

• Pain management: chronic and procedural.

• Rehabilitation: neurological and post-traumatic.

• Chronic disease management: diabetes, cardiovascular, respiratory.

The role of VR in DTx

Virtual reality is one of the most promising channels for DTx. Immersion makes it possible to deliver more intensive and effective interventions than a smartphone app. In oncology and pediatrics, therapeutic VR is opening up use cases that were previously impossible.

What to expect in the coming years

More direct prescribing, progressive reimbursement, and integration with electronic health records. DTx are becoming an integral part of clinical practice, not an alternative.